Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Raftery: Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness. (0.11 sec) 

Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness

- prsjournal.com
J Raftery, A Clegg, J Jones, SC Tan, A Lotery - British Journal of Ophthalmology, 2007 - bjo.bmj.com
Two new drugs provide startling benefits in the treatment of age-related macular
degeneration (AMD). The clinical and cost effectiveness of ranibizumab
(Lucentis) was compared to that of bevacizumab (Avastin), which costs up to ...
Cited by 38 - Related articles - BL Direct - All 6 versions

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

- shouxi.net
R Steinbrook - The New England journal of medicine, 2006 - nejm.highwire.org
O n June 30, 2006, the Food and Drug Adminis- tration (FDA) approved ranibizumab
— which is manufactured by Genentech and marketed as Lucentis — for the
treatment of neovascular age- ... Copyright © 2006 Massachusetts Medical ...
Cited by 91 - Related articles - BL Direct - All 6 versions

Trials that matter: two faces of progress in the treatment of age-related macular degeneration


P Epstein - Ann Intern Med, 2007 - 万方数据资源系统
Age-related macular degeneration (AMD) is a common ocular condition that may
destroy central vision and have a devastating effect on the quality of life of
people over the age of 55- Since the population of the United States is now ...
Cited by 8 - Related articles - All 2 versions

Targeting vascular endothelial growth factor: a promising strategy for treating age-related …

- duanessolution.com
M Waisbourd, A Loewenstein, M Goldstein, I … - Drugs &# 38; Aging, 2007 - ingentaconnect.com
Page 1. Drugs Aging 2007; 24 (8): 643-662 R EVIEW A RTICLE 1170-229X/07/0008-0643/
$44.95/0 © 2007 Adis Data Information BV. All rights reserved. ...
Cited by 17 - Related articles - BL Direct - All 7 versions

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related …


S Aisenbrey, F Ziemssen, M Völker, F … - Graefe's Archive for Clinical and Experimental …, 2006 - Springer
Abstract Background The purpose of the study is to report data on short-term
safety of intravitreal bevacizumab treatment and its effect on visual function,
central retinal thickness, and angiographical changes of occult choroidal ...
Cited by 49 - Related articles - BL Direct - All 3 versions

A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular …


MM Brown, GC Brown, HC Brown, J Peet - Ophthalmology, 2008 - Elsevier
Cited by 20 - Related articles - All 3 versions

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular …

- prsjournal.com
MV Emerson, AK Lauer, CJ Flaxel, DJ Wilson, … - Retina, 2007 - pdfs.journals.lww.com
Twenty eyes (25%) appeared to have a sustained response to a single injection
and did not require further injections through 3 months. Two patients had a
potentially drug-related adverse event (ischemic stroke and myocardial ...
Cited by 87 - Related articles - BL Direct - All 4 versions

[PDF] Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a …


JL Colquitt, J Jones, SC Tan, A Takeda, AJ … - Health Technol Assess, 2008 - hta.nhs.uk
Page 1. Ranibizumab and pegaptanib for the treatment of age-related macular
degeneration: a systematic review and economic evaluation ...
Cited by 11 - Related articles - All 4 versions

A prospective study on intravitreal bevacizumab (Avastin (R)) for neovascular age-related …


P Algvere, B Steen, S Seregard, A Kvanta… - Acta Ophthalmologica, 2008 - interscience.wiley.com
Methods: The case material comprised 36 subjects (26 females, 10 males) aged
65–88 years with subfoveal neovascular AMD with all subtypes of CNV. There
were two categories of patients: category I, long-standing CNV (12 months ...
Cited by 29 - Related articles - All 4 versions

[CITATION] MARINA Study Group (2007) Angiographic and Optical Coherence Tomographic Results of …


PK Kaiser, BA Blodi, H Shapiro, NR Acharya - Ophthalmology
Cited by 3 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google